TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19064513

Group type: COMPARATOR
Intervention: Vitamin D(3) 0 microg/d
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Vitamin D(3) 5 microg/d
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Vitamin D(3) 10 microg/d
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Vitamin D(3) 15 microg/d
Number of subjects: 238
Study: 16681964

Group type: EXPERIMENTAL
Intervention: Surgical resection (SR)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Percutaneous thermal ablation (PTA)
Number of subjects: 105
Study: 15115098

Group type: EXPERIMENTAL
Intervention: High-lactose Bifidobacterium bifidum-containing formula
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no high-lactose probiotic)
Number of subjects: 100
Study: 11138763

Group type: EXPERIMENTAL
Intervention: Listeners making specific responses (e.g., wincing, exclaiming)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Listeners making generic responses (e.g., nodding, vocalizations)
Number of subjects: 63
Study: 8791866

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ)
Number of subjects: 208
Study: 1645076

Group type: EXPERIMENTAL
Intervention: Urinary catheterisation
Number of subjects: 78

Group type: COMPARATOR
Intervention: Incontinence pads
Number of subjects: 78
Study: 6360259

Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 28
Study: 30408848

Group type: EXPERIMENTAL
Intervention: Concizumab
Number of subjects: 0
Study: 30366975

Group type: EXPERIMENTAL
Intervention: IV alteplase
Number of subjects: 2916

Group type: COMPARATOR
Intervention: Control
Number of subjects: 2916
Study: 26881789

Group type: EXPERIMENTAL
Intervention: Comprehensive Health Enhancement Support System (CHESS)
Number of subjects: 90
Study: 24159007

Group type: EXPERIMENTAL
Intervention: Focused nutrition educational intervention plus $6 in coupons redeemable at farmers markets
Number of subjects: 78

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 78
Study: 22270285

Group type: EXPERIMENTAL
Intervention: Single-incision mini-sling
Number of subjects: 263

Group type: COMPARATOR
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 263
Study: 19803399

Group type: EXPERIMENTAL
Intervention: IV rt‐PA therapy at a dose of 0.9 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IV rt‐PA therapy at a dose of 0.6 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: IV rt‐PA administered 3‐4.5 hours after symptom onset
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MRI-based thrombolysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of reperfusion therapies (IV rt‐PA and sonothrombolysis, neuroprotective agents, or antiplatelet agents)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher dose of alteplase, combined IV/IA thrombolysis, or mechanical thrombectomy
Number of subjects: 0
Study: 17488248

Group type: EXPERIMENTAL
Intervention: Intramuscular octreotide 20 mg (group A) q 4 wk for 3 months
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (group B)
Number of subjects: 18
Study: 14961057

Group type: EXPERIMENTAL
Intervention: Clomipramine 25 mg as needed
Number of subjects: 23

Group type: COMPARATOR
Intervention: Clomipramine 20 or 30 mg daily
Number of subjects: 23
Study: 12516788

Group type: EXPERIMENTAL
Intervention: 75 grams of superactivated charcoal (SAC) administered orally in a slurry 3 hours after acetaminophen dose
Number of subjects: 48

Group type: COMPARATOR
Intervention: No charcoal (control group)
Number of subjects: 48
Study: 9862941

Group type: EXPERIMENTAL
Intervention: Omeprazole and antibiotics (20 mg omeprazole orally twice daily, 500 mg amoxicillin three times daily, 400 mg metronidazole three times daily for 2 weeks)
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Omeprazole and antibiotics
Number of subjects: 318

Group type: COMPARATOR
Intervention: Omeprazole alone
Number of subjects: 318
Study: 9818646

Group type: EXPERIMENTAL
Intervention: Non-depleting humanized monoclonal antibody to CD4 (ORTHOCLONE OKTcdr4a) at a dosage of +/-450 mg per week for 2 treatment cycles, followed by a crossover to placebo for the third cycle.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2695726

Group type: EXPERIMENTAL
Intervention: 3 x 1 g claforan given during a period of 24 h (regimen I)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 1 x 1 g claforan given at the time of incision (regimen II)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Combination of cefapirin + gentamicin given in divided doses for 5 days (regimen III)
Number of subjects: 65
Study: 719463

Group type: EXPERIMENTAL
Intervention: Intravenous load of 11 of Hartmann's solution
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (no intravenous load)
Number of subjects: 104
Study: 31212508

Group type: EXPERIMENTAL
Intervention: CycleSampler method for generating surrogate networks with edge weights constrained to intervals and vertex strengths preserved exactly.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CycleSampler method for generating surrogate networks with both edge and vertex strengths constrained to intervals.
Number of subjects: 0
Study: 28533045

Group type: EXPERIMENTAL
Intervention: Animal-assisted therapy sessions
Number of subjects: 0
Study: 25593483

Group type: EXPERIMENTAL
Intervention: RetroView™ colonoscope in retroflexed withdrawal
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: RetroView™ colonoscope in combination withdrawal (standard + retroflexed)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: RetroView™ colonoscope in retroflexed withdrawal alone
Number of subjects: 5

Group type: COMPARATOR
Intervention: Conventional colonoscope in standard withdrawal
Number of subjects: 5
Study: 23974970

Group type: EXPERIMENTAL
Intervention: Laser‐assisted posterior cordotomy (Group A)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Diathermy‐assisted posterior cordotomy (Group B)
Number of subjects: 20
Study: 21689442

Group type: EXPERIMENTAL
Intervention: Edinburgh Postnatal Depression Scale (EPDS)
Number of subjects: 811
Study: 19785777

Group type: EXPERIMENTAL
Intervention: Usual teaching (lecture followed by group tutorial)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Problem Based Learning (PBL)
Number of subjects: 129
Study: 16910765

Group type: EXPERIMENTAL
Intervention: N-acetyl-cysteine (NAC) treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In vitro exposure of RBC to ROS/RNS
Number of subjects: 0
Study: 15242836

Group type: EXPERIMENTAL
Intervention: Hypoxic apnea
Number of subjects: 21

Group type: COMPARATOR
Intervention: Hypercapnic hypoxia
Number of subjects: 21

Group type: COMPARATOR
Intervention: Isocapnic hypoxia
Number of subjects: 21
Study: 11388971

Group type: EXPERIMENTAL
Intervention: Clinician-accompanied self-exposure
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Self-exposure
Number of subjects: 68

Group type: COMPARATOR
Intervention: Self-relaxation
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Self-exposure homework compliance
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Overall treatment need
Number of subjects: 68
Study: 9240144

Group type: EXPERIMENTAL
Intervention: Urgent carotid surgery
Number of subjects: 16

Group type: COMPARATOR
Intervention: Best medical care
Number of subjects: 16
Study: 7685687

Group type: EXPERIMENTAL
Intervention: Diclofenac alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Misoprostol alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diclofenac/misoprostol combination dosage form
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diclofenac (single and multiple doses) in elderly volunteers
Number of subjects: 0
Study: 3718599

Group type: EXPERIMENTAL
Intervention: Acemetacin (90 mg, single administration)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Acemetacin (2 retard capsules/d for 8 d, multiple administration)
Number of subjects: 14
Study: 29449080

Group type: EXPERIMENTAL
Intervention: MAX-LEG
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: MAX-ARM
Number of subjects: 13

Group type: COMPARATOR
Intervention: Submaximal LEG exercise
Number of subjects: 13

Group type: COMPARATOR
Intervention: Submaximal ARM exercise
Number of subjects: 13
Study: 26635335

Group type: EXPERIMENTAL
Intervention: Home-based walking program (Ti-To; n = 18)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Revascularization (Rev; n = 9)
Number of subjects: 27
Study: 24756483

Group type: EXPERIMENTAL
Intervention: 2g omega-3 PUFA daily, initiated 5 days before surgery
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control group (not treated with omega-3 PUFA)
Number of subjects: 198
Study: 22621326

Group type: EXPERIMENTAL
Intervention: 30% oxygen
Number of subjects: 200

Group type: COMPARATOR
Intervention: 65% oxygen
Number of subjects: 200
Study: 20570818

Group type: EXPERIMENTAL
Intervention: Real TMS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham TMS
Number of subjects: 0

Group type: COMPARATOR
Intervention: No TMS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Suprathreshold TMS on M1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Subthreshold TMS over M1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Peripheral arm stimulation
Number of subjects: 0
Study: 18310475

Group type: EXPERIMENTAL
Intervention: Optical coherence tomography (OCT)
Number of subjects: 44
Study: 16555574

Group type: EXPERIMENTAL
Intervention: Valsartan (40‐80 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 12438003

Group type: EXPERIMENTAL
Intervention: Dental technicians (exposed to chromium, cobalt, and nickel)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control subjects (not exposed)
Number of subjects: 27
Study: 10526740

Group type: EXPERIMENTAL
Intervention: GlucoWatch biographer glucose measurements in a controlled outpatient clinic setting
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: GlucoWatch biographer glucose measurements in a home setting
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: GlucoWatch biographer glucose measurements (two biographers worn simultaneously)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: GlucoWatch biographer glucose values
Number of subjects: 28
Study: 7732799

Group type: EXPERIMENTAL
Intervention: Sulprostone (prostaglandin E2 analogue)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Oxytocin and ergometrine (control group)
Number of subjects: 81
Study: 1974669

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beclomethasone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Broxaterol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verapamil, Ketotifen, Cromolyn
Number of subjects: 0
Study: 394576

Group type: EXPERIMENTAL
Intervention: VAC (Vincristine, Adriamycin, Cyclophosphamide)
Number of subjects: 64

Group type: COMPARATOR
Intervention: VACM (VAC with Methotrexate and citrovorum factor rescue)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: VAC
Number of subjects: 64

Group type: COMPARATOR
Intervention: VACM
Number of subjects: 64
Study: 31811715

Group type: EXPERIMENTAL
Intervention: Ticagrelor 60 mg or 90 mg plus aspirin
Number of subjects: 4199

Group type: COMPARATOR
Intervention: Placebo plus aspirin
Number of subjects: 4199
Study: 31662524

Group type: COMPARATOR
Intervention: 10 mg/day solifenacin
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Bilateral uterosacral ligament replacement, cervicosacropexy, or vaginosacropexy
Number of subjects: 96
Study: 28025862

Group type: EXPERIMENTAL
Intervention: Higher HDL-C at 36 weeks gestation
Number of subjects: 320

Group type: COMPARATOR
Intervention: Low HDL-C at 36 weeks gestation
Number of subjects: 320

Group type: COMPARATOR
Intervention: Low low-density lipoprotein cholesterol at 36 weeks gestation
Number of subjects: 320
Study: 25955579

Group type: EXPERIMENTAL
Intervention: Modified triangular cord thickness and gallbladder classification scheme
Number of subjects: 273

Group type: COMPARATOR
Intervention: Triangular cord thickness alone
Number of subjects: 273
Study: 23490379

Group type: EXPERIMENTAL
Intervention: albIFN 900/1200/1500 μg q4wk
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Peg‐IFNα‐2a 180 μg qwk
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: oral ribavirin 800 mg/d
Number of subjects: 391

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 391
Study: 21289240

Group type: EXPERIMENTAL
Intervention: Salsalate (4000 mg Disalsid)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Intralipid
Number of subjects: 9
Study: 19729945

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide (BUD) for 4 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: No budesonide treatment (Control)
Number of subjects: 30
Study: 17239709

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Simvastatin + Pioglitazone (Combination)
Number of subjects: 125
Study: 15278753

Group type: EXPERIMENTAL
Intervention: Oral enzyme‐rutosid combination (ERC)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Diclofenac
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 103
Study: 11602473

Group type: EXPERIMENTAL
Intervention: Additional job training, equal career opportunities, letting the disease influence the choice of the current job position, informing colleagues about having the disease
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Adjusting job demands
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Decreasing activities and diverting attention to cope with pain, pacing to cope with limitations
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Pacing
Number of subjects: 720
Study: 9236354

Group type: EXPERIMENTAL
Intervention: Nonpulsatile hypothermic (NP 28)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Pulsatile normothermic (P 37)
Number of subjects: 24

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 24

Group type: COMPARATOR
Intervention: Total-body oxygen consumption and extraction
Number of subjects: 24
Study: 7525170

Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 1104

Group type: EXPERIMENTAL
Intervention: Adult diabetic patients
Number of subjects: 1104

Group type: COMPARATOR
Intervention: Control group (n = 258)
Number of subjects: 1104

Group type: EXPERIMENTAL
Intervention: Insulin-treated adult diabetic patients
Number of subjects: 1104

Group type: EXPERIMENTAL
Intervention: Non-insulin-treated adult diabetic patients
Number of subjects: 1104

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 1104

Group type: EXPERIMENTAL
Intervention: Patients with elevated HbF
Number of subjects: 1104
Study: 3311105

Group type: EXPERIMENTAL
Intervention: Topical 1% indomethacin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Previous studies
Number of subjects: 0
Study: 29701043

Group type: EXPERIMENTAL
Intervention: Acupuncture plus clomiphene (electroacupuncture applied 30 min, continuous wave, 2 Hz, 3 times a week for 3 months)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Clomiphene (oral administration for 5 days starting from the 5th day of menstruation or medicine-withdrawal bleeding)
Number of subjects: 80
Study: 26670575

Group type: EXPERIMENTAL
Intervention: Transobturator tape (TOT)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Retropubic tension-free vaginal tape (TVT)
Number of subjects: 176
Study: 25576351

Group type: EXPERIMENTAL
Intervention: Disease management programs (DMPs) for 6 months including self-management education provided by a nurse and support from primary care physician
Number of subjects: 321

Group type: COMPARATOR
Intervention: Usual care (ordinary outpatient care)
Number of subjects: 321
Study: 23613786

Group type: EXPERIMENTAL
Intervention: MST+YOT
Number of subjects: 108

Group type: COMPARATOR
Intervention: YOT alone
Number of subjects: 108
Study: 20525993

Group type: EXPERIMENTAL
Intervention: Nilotinib 300 mg twice daily
Number of subjects: 846

Group type: EXPERIMENTAL
Intervention: Nilotinib 400 mg twice daily
Number of subjects: 846

Group type: COMPARATOR
Intervention: Imatinib 400 mg once daily
Number of subjects: 846
Study: 18845704

Group type: EXPERIMENTAL
Intervention: Medium chain triglyceride (MCT) oil
Number of subjects: 31

Group type: COMPARATOR
Intervention: Olive oil
Number of subjects: 31
Study: 16635175

Group type: EXPERIMENTAL
Intervention: Intensive asthma education program (group B)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard asthma education program (group A)
Number of subjects: 100
Study: 12482789

Group type: EXPERIMENTAL
Intervention: High dose lisinopril (32.5 or 35 mg)
Number of subjects: 3164

Group type: EXPERIMENTAL
Intervention: Low dose lisinopril (2.5 or 5 mg)
Number of subjects: 3164

Group type: EXPERIMENTAL
Intervention: Use of beta blockers or antiarrhythmic agents (mainly amiodarone)
Number of subjects: 3164

Group type: EXPERIMENTAL
Intervention: Long acting nitrates and previous use of angiotensin converting enzyme inhibitors
Number of subjects: 3164

Group type: EXPERIMENTAL
Intervention: Low systolic blood pressure at baseline, raised creatinine, reduced serum sodium or haemoglobin, and increased heart rate
Number of subjects: 3164
Study: 10658074

Group type: EXPERIMENTAL
Intervention: Open cholecystectomy (OC)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 28
Study: 8691702

Group type: EXPERIMENTAL
Intervention: Orchiectomy plus diethylstilbestrol diphosphate
Number of subjects: 39

Group type: COMPARATOR
Intervention: Orchiectomy plus diethylstilbestrol diphosphate plus combination chemotherapy with cisplatin and methotrexate
Number of subjects: 39
Study: 1379883

Group type: EXPERIMENTAL
Intervention: 6 mg of risperidone daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: 20 mg of haloperidol
Number of subjects: 0
Study: 6381185

Group type: EXPERIMENTAL
Intervention: Cimetidine 1.2 g/day
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Cimetidine 2.4 g/day
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 30742555

Group type: EXPERIMENTAL
Intervention: Lettuce harvested from Verticillium-infested fields
Number of subjects: 22
Study: 28551775

Group type: EXPERIMENTAL
Intervention: LBEC0101
Number of subjects: 48

Group type: COMPARATOR
Intervention: Enbrel®
Number of subjects: 48
Study: 26554773

Group type: EXPERIMENTAL
Intervention: MRC group (13 patients)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Surgery group (10 patients)
Number of subjects: 23
Study: 23023996

Group type: EXPERIMENTAL
Intervention: Pelviva(®) plus unsupervised pelvic floor muscle exercise
Number of subjects: 123

Group type: COMPARATOR
Intervention: Unsupervised pelvic floor muscle exercise alone
Number of subjects: 123
Study: 21059615

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Attention-control education
Number of subjects: 332

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 332
Study: 20426279

Group type: EXPERIMENTAL
Intervention: SMT + AO
Number of subjects: 53

Group type: COMPARATOR
Intervention: SMT
Number of subjects: 53
Study: 17196973

Group type: EXPERIMENTAL
Intervention: Relevant questions related to bridging inference
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Irrelevant questions related to bridging inference
Number of subjects: 32

Group type: COMPARATOR
Intervention: Adolescents with autism
Number of subjects: 32

Group type: COMPARATOR
Intervention: Normally developing adolescents
Number of subjects: 32
Study: 15013543

Group type: EXPERIMENTAL
Intervention: Condyles positioned in the centre of the articular fossa before and during the operation (14 patients, 28 TMJs)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Condyles not positioned in the centre of the articular fossa (14 patients, 28 TMJs)
Number of subjects: 28
Study: 11759022

Group type: EXPERIMENTAL
Intervention: Sterillium (liquid alcoholic rub-in hand disinfectant)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Hibiscrub (water-based handwashing antiseptic)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Sterillium
Number of subjects: 15

Group type: COMPARATOR
Intervention: Hibiscrub
Number of subjects: 15

Group type: COMPARATOR
Intervention: Alcoholic gels
Number of subjects: 15
Study: 9781721

Group type: EXPERIMENTAL
Intervention: cA2 (300 mg single dose)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 7878557

Group type: EXPERIMENTAL
Intervention: nedocromil sodium (4 mg) four times daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 50
Study: 3226339

Group type: EXPERIMENTAL
Intervention: 10 micrograms of ethinyl oestreadiol (EE)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 2 mg of oestradiol valerate (E2V)
Number of subjects: 24
Study: 31188700

Group type: EXPERIMENTAL
Intervention: Ischemic Preconditioning (IPC)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control
Number of subjects: 16
Study: 28347183

Group type: EXPERIMENTAL
Intervention: Transitional intervention aimed at improving social support during the transition from inpatient to outpatient care provided by a social worker
Number of subjects: 151

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 151
Study: 25697124

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress management (MBSM/Mindful-Gym) program
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study: 23506163

Group type: EXPERIMENTAL
Intervention: SL-PLUS stem
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: BetaCone stem
Number of subjects: 8

Group type: COMPARATOR
Intervention: Reference group (normal healthy hip)
Number of subjects: 8
Study: 21439048

Group type: EXPERIMENTAL
Intervention: Canakinumab 150 mg
Number of subjects: 200

Group type: COMPARATOR
Intervention: Triamcinolone acetonide 40 mg
Number of subjects: 200
Study: 17600772

Group type: EXPERIMENTAL
Intervention: Culturally-tailored after-school dance program and home/family-based intervention to reduce screen media use
Number of subjects: 261

Group type: COMPARATOR
Intervention: Information-based community health education Active-Placebo Comparison intervention
Number of subjects: 261
Study: 17139218

Group type: EXPERIMENTAL
Intervention: Operative treatment (short-segment posterior stabilization)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Nonsurgical treatment
Number of subjects: 34